A2m director sold off most of his a2m shares under $2 over 18...

First 17 Last

Bigfrank

330 Posts.

26/08/18

09:17

Post #: 35184362

Originally posted by OptiontraderMGR ↑

Hey Guys, how the hell do you all not think APT is currently not overpriced?

142 Million Revenue.
9 million in losses.
Market Cap 4 Billion.

Take MYO as one example of a stock with a market cap of 2 billion.

Column 1 Column 2 Column 3 Column 4

1 Key Financial Metrics
A$m; 6 mths ended 30 June

2 1H18
$m

3 1H17
$m

4 YoY %
change

5 Revenue

6 218.5

7 204.0

8 7%

9 Underlying EBITDA

10 92.7

11 89.6

12 3%

13 NPAT

14 25.3

15 28.3

16 (10%)

17 NPATA

18 45.6

19 48.5

20 (6%)

21 NPATA EPS (cents)

22 7.7

23 8.1

24 (5%)

Declared dividend return to shareholders of 5.75 cents @ 100% fully franked.

APT share price will in my humble opinion over the next 12 weeks slowly move back in price to reflect true value, less all the hype. Back to $14-$15 dollars.
My advice is do lots of research and be realistic with forward numbers. The golden rule in any stock is the share price will match the company’s earnings after the hype has died down.
Did you all notice the amount of shares all directors sold over the last 12 months?
In the annual report the total was 5,700,000 million shares sold by directors! Page31.
If the share price was “Undervalued” why would the “Directors” sell any of their holdings? Especially if the share price is going to $50.
Source:
https://hotcopper.com.au/threads/ann-fy2018-appendix-4e-and-annual-report.4379159/#.W4F4jOQnaUk
asx.com.au + MYO.

Expand

A2m director sold off most of his a2m shares under $2 over 18 months ago. How is that stock doing now now?

APT Price at posting: $19.69 Sentiment: Hold Disclosure: Held

9 Upvote

0 Great analysis

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 17 Last

Add APT (ASX) to my watchlist

	Column 1	Column 2	Column 3	Column 4
1	Key Financial Metrics A$m; 6 mths ended 30 June
2	1H18 $m
3	1H17 $m
4	YoY % change
5	Revenue
6	218.5
7	204.0
8	7%
9	Underlying EBITDA
10	92.7
11	89.6
12	3%
13	NPAT
14	25.3
15	28.3
16	(10%)
17	NPATA
18	45.6
19	48.5
20	(6%)
21	NPATA EPS (cents)
22	7.7
23	8.1
24	(5%)

A2m director sold off most of his a2m shares under $2 over 18...

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News